Precigen (PGEN) Change in Receivables (2012 - 2026)
Precigen (PGEN) reported Change in Receivables of $22.5 million for Q1 2026, up 29488.16% year-over-year from N/an in Q1 2025, and up 574.07% quarter-over-quarter from $3.3 million in Q4 2025.
Precigen (PGEN) Change in Receivables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Change in Receivables data on file, last reported at $22.5 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $22.5 million, up 29488.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.4 million (up 7750.9% YoY), and the FY2025 annual result was $3.0 million, up 782.65% from the prior year.
- Change in Receivables advanced to $22.5 million in Q1 2026 per PGEN's latest filing, from $3.3 million in the prior quarter.
- Over five years, Change in Receivables peaked at $22.5 million in Q1 2026 and troughed at -$12.4 million in Q4 2023.
- A 5-year average of $1.4 million and a median of -$15000.0 in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2026: Change in Receivables slumped 6454.55% in 2023, then soared 29488.16% in 2026.
- A 5-year view of Change in Receivables shows it stood at $11.6 million in 2022, then sank by 206.87% to -$12.4 million in 2023, then soared by 99.88% to -$15000.0 in 2024, then soared by 22340.0% to $3.3 million in 2025, then surged by 574.07% to $22.5 million in 2026.
- Business Quant data shows PGEN's Change in Receivables at $22.5 million in Q1 2026, $3.3 million in Q4 2025, and $253000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 22.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.49 Mn |
| Mar 31, 2026 | 22.49 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Sep 30, 2025 | 253,000.00 |
| Sep 30, 2025 | 253,000.00 |
| Jun 30, 2025 | -675,000.00 |
| Jun 30, 2025 | -675,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Jun 30, 2024 | -361,000.00 |
| Jun 30, 2024 | -361,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | -12.42 Mn |
| Dec 31, 2023 | -12.42 Mn |